“I accept this job with a thankful heart and the attitude that I will do everything possible to ensure my husband lives his best life, in the best quality possible. I count my blessings for each and every day I have with him.” By Georgette Bridger When I hear the words, “The Right
Jason Boehme, M.D., received the 2019 PHA Robyn J. Barst, M.D. Pediatric PH Research & Mentoring Grant in honor of Jackson Wall, one of three Pulmonary Hypertension Association (PHA) research grants awarded last year. An assistant professor of pediatrics at the University of California, San Francisco, Boehme is studying “Pulmonary Vascular Smooth Muscle Metabolic
The Social Security Administration (SSA) proposed changing the social security disability insurance (SSDI) process to make its eligibility review more frequent. PHA opposes the change and wrote to SSA in January to recommend that people with pulmonary hypertension (PH) undergo eligibility review less often. Currently, SSA reviews SSDI eligibility every year, every three years
In recognition of American Heart Month in February, the Pulmonary Hypertension Association’s (PHA’s) The Right Heart blog brings you a story about Lisa Goldstein. She recently was diagnosed with pulmonary arterial hypertension (PAH) related to Scimitar Syndrome, a congenital heart defect she only learned about as an adult. Lisa was diagnosed with Scimitar Syndrome in 2013
When Jeri Nudell was at the Pulmonary Hypertension Association’s (PHA’s) International PH Conference and Scientific Sessions in Orlando in 2018, she met an inspiring fellow attendee. In their long conversation, Charlotte Gilbert told Jeri that she was no longer blogging because her PH had progressed too much. Jeri shared that she had never been
“This year, 2020, has brought me new challenges, but it has also brought me new hope. I feel connected to patients like me, patients I can finally relate to.” I was diagnosed with pulmonary arterial hypertension (PAH) on Dec. 18, 2019, which came about by a congenital heart defect, Scimitar Syndrome. My
Researchers who study pulmonary hypertension (PH) can apply now to advance their research at the PHA 2020 International PH Conference and Scientific Sessions, which brings the PH community to Anaheim, California, to learn, connect and share a focus on a common “Vision for a Cure.” In addition, all attendees at PHA 2020 may take
Ke Yuan, Ph.D., received the 2019 PHA Aldrighetti Research Award for Young Investigators, with sponsorship support provided by Actelion Pharmaceuticals, U.S. The award, one of three Pulmonary Hypertension Association (PHA) research grants awarded last year, funds Yuan’s proposal, “SDF1 signaling: A Master Regulator of Mural Cell-Dependent Vascular Remodeling in PAH.” Yuan is an associate
The Pulmonary Hypertension Association’s (PHA’s) The Right Heart blog brings you a story about Aubrey Stout, who lives with idiopathic pulmonary arterial hypertension (PAH). Life hasn’t always been easy for Aubrey over the last 10 years since was diagnosed with PAH. She has experienced multiple life changes as she has adapted to her life
The Pulmonary Hypertension Association (PHA) joins other organizations and individuals in recognition of American Heart Month during February. Many individuals with pulmonary hypertension (PH) also have heart disease. More than 1.4 million U.S. adults have congenital heart disease (CHD), and between 3% and 10% of people with CHD will develop PH or high blood pressure
